Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Appendix B: Panel Roster and Financial Disclosures

TB

Last Updated: August 1, 2019; Last Reviewed: August 1, 2019

Mycobacterium tuberculosis Infection and Disease
Member Financial Disclosure
Company Relationship
Brust, James* Albert Einstein College of Medicine None N/A
Dooley, Kelly Johns Hopkins University None N/A
Heysell, Scott University of Virginia Bill and Melinda Gates Foundation Research Support
Elton John AIDS Foundation Research Support
National Institutes of Health Research Support
UpToDate Royalties
Maartens, Gary University of Cape Town, South Africa ViiV Advisory Board
Meintjes, Graeme University of Cape Town, South Africa Bill and Melinda Gates Foundation Research Support
Shah, Sarita Centers for Disease Control and Prevention None N/A
Sterling, Timothy Vanderbilt University Medical Center Centers for Disease Control and Prevention Research Support
CRDF Global Research Support
National Institutes of Health Research Support
UpToDate Royalties
*Group lead

Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.

Download Guidelines